Contract Notice Open House Treaties For Several Active Ingredients Active Ingredient CombinationsPharmaceutical ProductsShort Description The Subject Of This Publication Is The Conclusion Of Contracts Pursuant To Section 130A 8 Sgb V On The Following Active Substances Active Ingredient Combinations Within The Framework Of A So Called Open House Method Abatacept L04aa24 Acetylsalicylic Acid B01ac06 Exclusively According To Appendix I Am Rl Regulatory ProductsDesloratadin R06ax27 Ertugloflozin A10bk04 Gestagen Estrogens As A Vaginal Ring G02bb01 Goserelin H01ca05 L02ae03 Presentation Of Uniform Contract Terms And A Uniform Access Procedure All Appropriate And Interested Pharmaceutical Companies Or Communities Of Pharmaceutical Companies Is Offered To Conclude A Discount Agreement Pursuant To Section 130A 8 Sgb V Above The Above Mentioned Active Ingredients Active Ingredient Combinations The Earliest Start Of The Contract Is 01 06 2022 Based On This The Contract Period Is A Maximum Of 24 Months Deadline For Submission 20240401 17 00Type Of Buyer Body Governed By Public LawType Of Contract SuppliesType Of Procedure Open ProcedureRegulation European UnionType Of Bid Submission For All LotsAward Criteria Lowest Price Disclaimer The Above Text Is Machine Translated For Accurate Information Kindly Refer The Original Document
Dear Sir,
Warm Greetings from TenderDetail.com !!
We have received Tender Document request for the TDR No : 50201251
Tender Notice along with it's Attachments ( Tender Document / Scan Image of News Paper)
sent to your Email Address :.
Please check your email for Tender Document.